Stryker Corporation news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

SYK 80.41 +0.19 (0.24%)
price chart
Stryker Corporation (SYK) Insider Ronda Stryker Continues Stock Sale by ...
It appears that Stryker Corporation (NYSE:SYK)'s Director, Ronda Stryker is set to continue her sale streak this week, as the insider unloaded yet again 7,000 shares of Common Stock today.
Inside Move: PHH Corp (NYSE:PHH), Stryker (NYSE:SYK), Allergan (NYSE:AGN ...  eMarketsDaily
Related articles »  
Insider Selling: Ronda E. Stryker Sells 14000 Shares of Stryker Stock (SYK)
Stryker (NYSE:SYK) opened at 80.22 on Wednesday. Stryker has a 52-week low of $66.44 and a 52-week high of $86.93. The stock's 50-day moving average is $83.6 and its 200-day moving average is $81.17.
Insider Selling: Stryker Director Sells 14000 Shares of Stock (SYK)  Watch List News (press release)
Related articles »  
Mariel Therapeutics Announces Definitive Agreement to Acquire Stryker's BMP-7 ...
NEW YORK, July 7, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc. today announced that it has entered into a definitive agreement to acquire Stryker Corporation's (NYSE:SYK) Bone Morphogenetic Protein-7 (BMP-7) assets for the potential treatment of ...
Mariel Therapeutics Acquires Stryker Assets
Mariel Therapeutics Will Acquire Stryker's (SYK) BMP-7 Assets (subscription)
Related articles »  
Stryker Corporation Stock Coming Through With Growth
Stryker (NYSE: SYK ) has been a fairly strong stock this year, and why not? The company addresses several attractive markets within med-tech and shown a willingness (and capability) to effectively deploy capital toward business-building M&A transactions.
Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M ...
In March, Stryker Corporation's Orthopaedics Division and the PGA TOUR announced a new marketing relationship that designates Stryker as the "Official Joint Replacement Products of the PGA TOUR and Champions Tour.
Related articles »  
Mariel Therapeutics Acquires Stryker Assets - Analyst Blog
Mariel Therapeutics, Inc., a clinical stage biopharmaceutical company, entered into a definitive agreement to acquire Stryker Corporation's ( SYK ) Bone Morphogenetic Protein-7 (BMP-7) assets. The BMP-7 assets of the MI-based medical device provider ...
Stryker - Strikes Again After Announcing Yet Another Acquisition This Year (SYK)
Back in April of this year, Stryker reported its first-quarter results. Total cash, equivalents and marketable securities stood at $4.05 billion, giving the company plenty of liquidity to make such deals. Total debt of $3.06 billion leaves a solid net ...
Stryker Acquires Joint Replacement System Maker
Related articles »  
Today's After Hours Earnings: Capital One Financial Corp., Schlumberger ...
Stryker Corp (SYK ) reported second quarter revenues of $2.4 billion, which are up from last year's Q2 revenues of $2.2 billion.
Stryker (SYK) Posts Quarterly Earnings, Hits Estimates  Ticker Report
Stryker Given Average Rating of �Hold� by Analysts (NYSE:SYK)  Intercooler
Related articles »  
Stryker Continues Growth Spree via Acquisitions - Analyst Blog
However, Stryker faces strong competition from Johnson & Johnson ( JNJ ). It also faces obstacles for becoming a major medtech company from a couple of recent M&A activities. They include the merger announcements between Medtronic, Inc. ( MDT ) and ...
Stryker Given Average Rating of �Buy� by Brokerages (NYSE:SYK)  WKRB News
Related articles »  
Healthcare Insider Selling: Illumina (NASDAQ:ILMN), Raptor Pharmaceutical ...
Following the completion of the sale, the director now directly owns 174,605 shares in the company, valued at approximately $14,874,600.
Related articles »